Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $1.77 Analyst target: $17.00 Upside: 860.45%
Seres Therapeutics, Inc., a microbiome therapeutic platform company, is involved in the development of bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company is headquartered in Cambridge, Massachusetts.
See the full interactive analysis & chart →Informational only — not investment advice.